Strata Oncology, Inc., a next-generation precision oncology company enabling smarter and earlier cancer treatment, today announced the integration of discrete genomic data from its StrataNGS® next-generation sequencing-based tumor profiling with the University of Wisconsin Carbone Cancer Center and UW Health Epic genomics module.

The integration will streamline workflows for physicians by creating an easily-accessible and user-friendly database, allowing them to more quickly identify the optimal therapy for each patient with cancer. This integration will also enable the institution to expand its research and understanding of cancer.

“For many oncologists, genomic reports are inaccessible in hard-to-find scanned documents,” said Mark Burkard, M.D., Ph.D., associate director of genomics and precision medicine at the University of Wisconsin Carbone Cancer Center. “With the help of Strata Oncology and our UW Healthlink Builders, we have finally integrated genomic findings directly into our electronic medical records system (EMR). Now, physicians will have genomics at their fingertips, and as we learn more about them, we can easily search the EMR for affected patients and alert their physicians. This collaboration will ensure that UW Health and University of Wisconsin Carbone Cancer Center delivers remarkable care.”

“By integrating data from StrataNGS into the Epic genomics module, the University of Wisconsin Carbone Cancer Center will be able to more efficiently and effectively use genomic data to treat and understand cancer,” said Dan Rhodes, Ph.D., co-founder and Chief Executive Officer, Strata Oncology. “We believe that the future of cancer care will depend heavily on dynamic information and reporting. This integration is a major step toward that, and toward delivering the best possible treatment to every patient with cancer.”